Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
5)44-28/h9-11
It competitively inhibits acetyl-lysine binding of the first but not the second bromodomain of BET proteins in cell extracts
015-2 μM) inhibits FcεRI-mediated basophil degranulation with an IC50 of 0
Solubility: DMSO : 50 mg/mL (79
Faropenem Catalog No.:M16831-C 5)44-28/h9-11Faropenem is a potent and orally active beta lactam antibiotic. Faropenem demonstrates broad spectrum in vitro antimicrobial activity against many gram positive and negative aerobes and anaerobes. Faropenem is resistant to hydrolysis by nearly all beta lactamases, including extended spectrum beta lactamases and AmpC beta lactamases. Faropenem is developed as an oral prodrug, faropenem medoxomil, for the research of respiratory tract infections.
US$ 1273.00
US$ 23.00
US$ 1304.50
US$ 24250.00
US$ 38250.00
US$ 23.00
US$ 55000.00